Transcend Therapeutics
Lee Schalop is biotech entrepreneur and angel investor. He co-founded and served as Chief Executive Officer of Oncoceutics, Inc., a clinical-stage drug discovery and development company with a novel brain cancer drug, until its sale to Chimerix in January 2021. He previously served as the company’s Chief Operating Officer and prior to that as the company’s Chief Business Officer. Prior to co-founding Oncoceutics, Dr. Schalop attended the Albert Einstein College of Medicine, graduating with a doctor of medicine degree in 2008. Prior to attending medical school, Dr. Schalop spent more than 19 years in the financial industry at a number of major Wall Street firms, including Morgan Stanley, J.P. Morgan, Credit Suisse and Banc of America Securities.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Transcend Therapeutics
1 followers
Transcend Therapeutics is a clinical-stage, neuroscience-focused company developing next-generation psychoactive medicines for neuropsychiatric disease. Transcend develops medicines that are accessible to a larger percentage of patients in need, specifically the tens of millions of patients who already take psychotropic medication. We have real-world data showing that our lead product provided significant benefit to >85% of patients with PTSD and depression. We have already advanced our lead compound into an approved Phase II study in PTSD, with plans to expand into depression and other indications.